LGR5 Enhances the Osteoblastic Differentiation of MC3T3-E1 Cells Through the Wnt/β-catenin Pathway

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2021 Jul 1

PMID 34194567

Citations 3

Authors

Wei Yu

Chao-Ran Xie

Fan-Cheng Chen

Pei Cheng

Lei Yang

Xiao-Yun Pan

Affiliations

Soon will be listed here.

Abstract

Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) is a Wnt-associated gene that contributes to cell proliferation and self-renewal in various organs. LGR5 is expressed in Ewing sarcoma, and LGR5-overexpressing mesenchymal stem cells promote fracture healing. However, the effects of LGR5 on osteoblastic differentiation remain unclear. The aim of the present study was to explore the function of LGR5 in osteoblastic differentiation. LGR5 was overexpressed or knocked down in the MC3T3-E1 pre-osteoblastic cell line via lentiviral transfection and its function in osteoblastic differentiation was investigated. The mRNA expression levels of the osteoblast differentiation markers alkaline phosphatase (ALP), osteocalcin and collagen type I a1 were determined, and ALP and Alizarin red staining were performed. In addition, the effects of LGR5 modulation on β-catenin and the expression of target genes in the Wnt pathway were investigated. The results revealed that the overexpression of LGR5 promoted osteoblastic differentiation. This was associated with enhancement of the stability of β-catenin and its levels in the cell nucleus, which enabled it to activate Wnt signaling. By contrast, the inhibition of LGR5 decreased the osteogenic capacity of MC3T3-E1 cells. These results indicate that LGR5 is a positive regulator of osteoblastic differentiation, whose effects are mediated through the Wnt/β-catenin signaling pathway. This suggests suggesting that the regulation of LGR5/Wnt/β-catenin signaling has potential as a therapy for osteoporosis.

Citing Articles

The role and mechanism of β-catenin-mediated skeletal muscle satellite cells in osteoporotic fractures by Jian-Pi-Bu-Shen formula.

Tang Y, Mu Z, Pan D, Liu R, Hong S, Xiong Z J Mol Histol. 2024; 55(5):875-893.

PMID: 39105942 DOI: 10.1007/s10735-024-10238-w.

Effect of nicotinamide mononucleotide on osteogenesis in MC3T3-E1 cells against inflammation-induced by lipopolysaccharide.

Kang I, Koo M, Jun J, Lee J Clin Exp Reprod Med. 2024; 51(3):236-246.

PMID: 38599888 PMC: 11372314. DOI: 10.5653/cerm.2023.06744.

Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis.

Huang X, Li S, Lu W, Xiong L BMC Endocr Disord. 2022; 22(1):189.

PMID: 35869471 PMC: 9306077. DOI: 10.1186/s12902-022-01103-6.

References

Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z . Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development. 2009; 136(16):2747-56. PMC: 2730404. DOI: 10.1242/dev.033571. View

de Lau W, Barker N, Low T, Koo B, Li V, Teunissen H . Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature. 2011; 476(7360):293-7. DOI: 10.1038/nature10337. View

Xu J, Huang C, Yang Z, Jin M, Fu P, Zhang N . Crystal structure of LGR4-Rspo1 complex: insights into the divergent mechanisms of ligand recognition by leucine-rich repeat G-protein-coupled receptors (LGRs). J Biol Chem. 2014; 290(4):2455-65. PMC: 4303694. DOI: 10.1074/jbc.M114.599134. View

Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013; 19(2):179-92. DOI: 10.1038/nm.3074. View

Luo J, Yang Z, Ma Y, Yue Z, Lin H, Qu G . LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med. 2016; 22(5):539-46. DOI: 10.1038/nm.4076. View

Barker N, van Es J, Kuipers J, Kujala P, van den Born M, Cozijnsen M . Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449(7165):1003-7. DOI: 10.1038/nature06196. View

Black D, Rosen C . Clinical Practice. Postmenopausal Osteoporosis. N Engl J Med. 2016; 374(3):254-62. DOI: 10.1056/NEJMcp1513724. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Plaks V, Brenot A, Lawson D, Linnemann J, van Kappel E, Wong K . Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Rep. 2013; 3(1):70-8. PMC: 3563842. DOI: 10.1016/j.celrep.2012.12.017. View

10.

Glinka A, Dolde C, Kirsch N, Huang Y, Kazanskaya O, Ingelfinger D . LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep. 2011; 12(10):1055-61. PMC: 3185347. DOI: 10.1038/embor.2011.175. View

11.

Kemper K, Prasetyanti P, de Lau W, Rodermond H, Clevers H, Medema J . Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells. 2012; 30(11):2378-86. DOI: 10.1002/stem.1233. View

12.

Vieira G, Chockalingam S, Melegh Z, Greenhough A, Malik S, Szemes M . LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Oncotarget. 2015; 6(37):40053-67. PMC: 4741879. DOI: 10.18632/oncotarget.5548. View

13.

Barker N, Clevers H . Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 2010; 138(5):1681-96. DOI: 10.1053/j.gastro.2010.03.002. View

14.

Barker N, Huch M, Kujala P, van de Wetering M, Snippert H, van Es J . Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010; 6(1):25-36. DOI: 10.1016/j.stem.2009.11.013. View

15.

Morita H, Mazerbourg S, Bouley D, Luo C, Kawamura K, Kuwabara Y . Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension. Mol Cell Biol. 2004; 24(22):9736-43. PMC: 525477. DOI: 10.1128/MCB.24.22.9736-9743.2004. View

16.

Gong X, Carmon K, Lin Q, Thomas A, Yi J, Liu Q . LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS One. 2012; 7(5):e37137. PMC: 3355120. DOI: 10.1371/journal.pone.0037137. View

17.

Jiang M, Wang T, Yan X, Liu Z, Yan Y, Yang K . A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss. J Bone Miner Res. 2018; 34(2):361-374. DOI: 10.1002/jbmr.3604. View

18.

Xu L, Lin W, Wen L, Li G . Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy. Stem Cell Res Ther. 2019; 10(1):219. PMC: 6664754. DOI: 10.1186/s13287-019-1288-8. View

19.

Leder B . Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy. Curr Osteoporos Rep. 2017; 15(2):110-119. PMC: 5477638. DOI: 10.1007/s11914-017-0353-4. View

20.

Liu D, He X, Qian P, Barker N, Trainor P, Clevers H . Leucine-rich repeat-containing G-protein-coupled Receptor 5 marks short-term hematopoietic stem and progenitor cells during mouse embryonic development. J Biol Chem. 2014; 289(34):23809-16. PMC: 4156055. DOI: 10.1074/jbc.M114.568170. View